Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Ruixia Du

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5051985725, A5067283047. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Natural Compounds as Potential Therapeutics for Pancreatic Cancer: A Narrative Review. Co-author DOI 10.2174/0113892002393013250812093213↗
  2. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. First author DOI 10.3978/j.issn.1000-9604.2015.04.06↗
  3. microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1. Last author DOI 10.3978/j.issn.1000-9604.2015.04.07↗
  4. JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells. First author DOI 10.1007/s13277-012-0404-5↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingda Lin · 1 shared paper, 2025 · strength 0.33
  2. Zhe Liu · 1 shared paper, 2025 · strength 0.33
  3. Kejian Guo · 3 shared papers, 2012–2015 · strength 0.15
  4. Jin Long · 3 shared papers, 2012–2015 · strength 0.15
  5. Yuanhong Xu · 2 shared papers, 2012–2015 · strength 0.09
  6. Chunlin Ge · 1 shared paper, 2015 · strength 0.06
  7. Yuanhong Xu · 1 shared paper, 2015 · strength 0.06
  8. Zhe Liu · 1 shared paper, 2015 · strength 0.06
  9. Zhe Liu · 1 shared paper, 2015 · strength 0.06
  10. Chunlin Ge · 1 shared paper, 2015 · strength 0.06
  11. Zhe Liu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.